JPWO2023019241A5 - - Google Patents
Info
- Publication number
- JPWO2023019241A5 JPWO2023019241A5 JP2024508568A JP2024508568A JPWO2023019241A5 JP WO2023019241 A5 JPWO2023019241 A5 JP WO2023019241A5 JP 2024508568 A JP2024508568 A JP 2024508568A JP 2024508568 A JP2024508568 A JP 2024508568A JP WO2023019241 A5 JPWO2023019241 A5 JP WO2023019241A5
- Authority
- JP
- Japan
- Prior art keywords
- effective amount
- liposomes
- weeks
- tau
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163260227P | 2021-08-12 | 2021-08-12 | |
| US63/260,227 | 2021-08-12 | ||
| US202163263541P | 2021-11-04 | 2021-11-04 | |
| US63/263,541 | 2021-11-04 | ||
| US202263267975P | 2022-02-14 | 2022-02-14 | |
| US63/267,975 | 2022-02-14 | ||
| PCT/US2022/074902 WO2023019241A2 (en) | 2021-08-12 | 2022-08-12 | Liposomes containing phosphorylated tau peptides for inducing sustained immune responses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024532787A JP2024532787A (ja) | 2024-09-10 |
| JP2024532787A5 JP2024532787A5 (https=) | 2025-08-19 |
| JPWO2023019241A5 true JPWO2023019241A5 (https=) | 2025-08-19 |
Family
ID=85201019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508568A Pending JP2024532787A (ja) | 2021-08-12 | 2022-08-12 | 持続的な免疫応答を誘導するためのリン酸化タウペプチドを含むリポソーム |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20250134973A1 (https=) |
| EP (1) | EP4384216A4 (https=) |
| JP (1) | JP2024532787A (https=) |
| KR (1) | KR20240042508A (https=) |
| AU (1) | AU2022328342A1 (https=) |
| CA (1) | CA3228878A1 (https=) |
| CL (1) | CL2024000408A1 (https=) |
| IL (1) | IL310761A (https=) |
| JO (1) | JOP20240028A1 (https=) |
| MX (1) | MX2024001906A (https=) |
| WO (1) | WO2023019241A2 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3239368A1 (en) * | 2009-06-10 | 2010-12-16 | New York University | Immunological targeting of pathological tau proteins |
| KR102710762B1 (ko) * | 2017-10-25 | 2024-09-25 | 얀센 파마슈티칼즈, 인코포레이티드 | 인산화 타우 펩티드의 조성물 및 이의 용도 |
| AU2020219804A1 (en) * | 2019-02-08 | 2021-08-19 | Ac Immune S.A. | Method of safe administration of phosphorylated Tau peptide vaccine |
| EA202192891A1 (ru) * | 2019-04-24 | 2022-02-04 | Янссен Фармасьютикалз, Инк. | Гетерологичное введение анти-тау вакцин |
-
2022
- 2022-08-12 JP JP2024508568A patent/JP2024532787A/ja active Pending
- 2022-08-12 KR KR1020247007914A patent/KR20240042508A/ko active Pending
- 2022-08-12 AU AU2022328342A patent/AU2022328342A1/en active Pending
- 2022-08-12 WO PCT/US2022/074902 patent/WO2023019241A2/en not_active Ceased
- 2022-08-12 MX MX2024001906A patent/MX2024001906A/es unknown
- 2022-08-12 US US18/683,001 patent/US20250134973A1/en active Pending
- 2022-08-12 IL IL310761A patent/IL310761A/en unknown
- 2022-08-12 EP EP22856833.3A patent/EP4384216A4/en active Pending
- 2022-08-12 CA CA3228878A patent/CA3228878A1/en active Pending
-
2023
- 2023-06-28 US US18/343,349 patent/US20230338535A1/en not_active Abandoned
-
2024
- 2024-02-09 CL CL2024000408A patent/CL2024000408A1/es unknown
- 2024-02-12 JO JOJO/P/2024/0028A patent/JOP20240028A1/ar unknown
-
2025
- 2025-01-06 US US19/010,408 patent/US20250144212A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI868106B (zh) | 安全投予磷酸化Tau胜肽疫苗的方法 | |
| TWI827557B (zh) | Ｔａｕ胜肽之組成物及其用途 | |
| JP7617852B2 (ja) | タウワクチンの異種投与 | |
| US20230218730A1 (en) | Vaccine therapy for ran protein diseases | |
| EP2300494A1 (en) | Anti-amyloid immunogenic compositions, methods and uses | |
| KR20230087499A (ko) | 알츠하이머 질환 치료용 멀티에피토프 백신 | |
| Oscherwitz et al. | Low-dose intraperitoneal Freund's adjuvant: Toxicity and immunogenicity in mice using an immunogen targeting amyloid-β peptide | |
| EP2698164B1 (en) | Dna vaccine | |
| JPWO2020163730A5 (https=) | ||
| JPWO2023019241A5 (https=) | ||
| US20250144212A1 (en) | Liposomes containing phosphorylated tau peptides for inducing sustained immune responses | |
| CN119894531A (zh) | Tau肽免疫原构建体 | |
| HK40061379A (en) | Method of safe administration of phosphorylated tau peptide vaccine | |
| EA051841B1 (ru) | Липосомы, содержащие фосфорилированные тау-пептиды, для индукции стойких иммунных ответов | |
| JPWO2023056369A5 (https=) | ||
| CN118660717A (zh) | 抗α-突触核蛋白的治疗性疫苗 | |
| EA045311B1 (ru) | Способ безопасного введения вакцины фосфорилированного пептида tau | |
| HK40039870A (en) | Compositions of phosphorylated tau peptides and uses thereof | |
| HK1194987B (en) | Dna vaccine |